AgingResearch.NewsJoin free

Protein Sciences Corporation

CompanyUnited States

Protein Sciences Corporation develops one asset, in phase 3 (FLU-v in influenza). Mostly vaccine acting on inflammation; based in the United States.

1
Asset
Furthest stage
Phase 3
1
Trial
0
Signals

Pipeline

1

  • FLU-v

    Inactivated influenza virus vaccine inducing protective antibody responses

    Phase 3, Vaccine, Inflammation, influenza, influenza immunization

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials2
  • Integrity notices1
  • Similar companies6

Intelligence